Pro-inflammatory Effects of Influenza Type A Virus PB1-F2 Protein-derived Peptide in Lipopolysaccharide-treated Macrophages
Influenza A virus (IAV) has the potential to cause pandemics with considerable health and socio-economic burdens. A viral protein, polymerase basic 1- frame2 (PB1-F2), as a virulence factor, has pro-apoptotic activity and contributes to viral pathogenesis by delaying viral clearance and inducing inf...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2020-05-01
|
Series: | Iranian Journal of Allergy, Asthma and Immunology |
Subjects: | |
Online Access: | https://ijaai.tums.ac.ir/index.php/ijaai/article/view/2366 |
_version_ | 1818523403159601152 |
---|---|
author | Kurosh Kalantar Zahra Farzaneh Nasser Gholijani Seyed Younes Hosseini Ebrahim Bani Hasan |
author_facet | Kurosh Kalantar Zahra Farzaneh Nasser Gholijani Seyed Younes Hosseini Ebrahim Bani Hasan |
author_sort | Kurosh Kalantar |
collection | DOAJ |
description | Influenza A virus (IAV) has the potential to cause pandemics with considerable health and socio-economic burdens. A viral protein, polymerase basic 1- frame2 (PB1-F2), as a virulence factor, has pro-apoptotic activity and contributes to viral pathogenesis by delaying viral clearance and inducing inflammation. Macrophages are susceptible to IAV infection and produce high levels of inflammatory cytokines and chemokines. In the present study, the pro-inflammatory effects of PB1-F2 derived peptide was evaluated by measuring the expression of key inflammatory mediators in murine macrophage cell line J774.1.
PB1-F2 treated macrophages were examined for nitric oxide (NO) production, inflammatory cytokines, and enzymes expression and pro-inflammatory cytokines secretion using Griess reagent, real-time polymerase chain reaction (PCR) and ELISA, respectively. Our results have shown that PB1-F2 peptide at non-cytotoxic concentrations (0.1–0.8 µmol/mL) had no effect on NO production.
When applied to Lipopolysaccharide (LPS)-treated macrophages, PB1-F2 peptide at 0.8 μmol/mLincreasedinducible NO synthase (iNOS), cyclooxygenase (COX)-2, and interleukin (IL)-6 genes expression to 2.02, 3.81, and 3.65 folds, respectively. PB1-F2 at concentrations of 0.4 and 0.8 µm/mL increased tumor necrosis factor (TNF)-α transcription by 4.15 and 5.55 fold. At posttranslational level, TNF-α increased from 166.5±13.88 in LPS-treated cells to 773.6±95.27 and 1485±76.31 at concentrations of 0.4 and 0.8 μmol/mL in PB1-F2 peptide, respectively. However, PB1-F2 Peptide did not have any significant effect on IL-6 production.
These findings suggest that PB1-F2 peptide may partly exert its enhancing role in viral pathogenicity through the induction of inflammatory mediators in macrophages. Hence, targeting PB1-F2 peptide would be helpful in the reduction of viral infection complications. |
first_indexed | 2024-12-11T05:44:30Z |
format | Article |
id | doaj.art-bfde57f955294317b77c68423ead82c8 |
institution | Directory Open Access Journal |
issn | 1735-1502 1735-5249 |
language | English |
last_indexed | 2024-12-11T05:44:30Z |
publishDate | 2020-05-01 |
publisher | Tehran University of Medical Sciences |
record_format | Article |
series | Iranian Journal of Allergy, Asthma and Immunology |
spelling | doaj.art-bfde57f955294317b77c68423ead82c82022-12-22T01:19:02ZengTehran University of Medical SciencesIranian Journal of Allergy, Asthma and Immunology1735-15021735-52492020-05-0119S110.18502/ijaai.v19i(s1.r1).28632366Pro-inflammatory Effects of Influenza Type A Virus PB1-F2 Protein-derived Peptide in Lipopolysaccharide-treated MacrophagesKurosh Kalantar0Zahra Farzaneh1Nasser Gholijani2Seyed Younes Hosseini3Ebrahim Bani Hasan4Department of Immunology, Medical School, Shiraz University of Medical Sciences, Shiraz, IranDepartment of Immunology, Medical School, Shiraz University of Medical Sciences, Shiraz, IranAutoimmune Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, IranDepartment of Bacteriology and Virology, Shiraz University of Medical Sciences, Shiraz, IranAustralian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St. Albans, VIC, Australia AND Department of Medicine-Western Health, The University of Melbourne, St. Albans, VIC, AustraliaInfluenza A virus (IAV) has the potential to cause pandemics with considerable health and socio-economic burdens. A viral protein, polymerase basic 1- frame2 (PB1-F2), as a virulence factor, has pro-apoptotic activity and contributes to viral pathogenesis by delaying viral clearance and inducing inflammation. Macrophages are susceptible to IAV infection and produce high levels of inflammatory cytokines and chemokines. In the present study, the pro-inflammatory effects of PB1-F2 derived peptide was evaluated by measuring the expression of key inflammatory mediators in murine macrophage cell line J774.1. PB1-F2 treated macrophages were examined for nitric oxide (NO) production, inflammatory cytokines, and enzymes expression and pro-inflammatory cytokines secretion using Griess reagent, real-time polymerase chain reaction (PCR) and ELISA, respectively. Our results have shown that PB1-F2 peptide at non-cytotoxic concentrations (0.1–0.8 µmol/mL) had no effect on NO production. When applied to Lipopolysaccharide (LPS)-treated macrophages, PB1-F2 peptide at 0.8 μmol/mLincreasedinducible NO synthase (iNOS), cyclooxygenase (COX)-2, and interleukin (IL)-6 genes expression to 2.02, 3.81, and 3.65 folds, respectively. PB1-F2 at concentrations of 0.4 and 0.8 µm/mL increased tumor necrosis factor (TNF)-α transcription by 4.15 and 5.55 fold. At posttranslational level, TNF-α increased from 166.5±13.88 in LPS-treated cells to 773.6±95.27 and 1485±76.31 at concentrations of 0.4 and 0.8 μmol/mL in PB1-F2 peptide, respectively. However, PB1-F2 Peptide did not have any significant effect on IL-6 production. These findings suggest that PB1-F2 peptide may partly exert its enhancing role in viral pathogenicity through the induction of inflammatory mediators in macrophages. Hence, targeting PB1-F2 peptide would be helpful in the reduction of viral infection complications.https://ijaai.tums.ac.ir/index.php/ijaai/article/view/2366InflammationInfluenza A virusMacrophagePolymerase basic–frame-2 |
spellingShingle | Kurosh Kalantar Zahra Farzaneh Nasser Gholijani Seyed Younes Hosseini Ebrahim Bani Hasan Pro-inflammatory Effects of Influenza Type A Virus PB1-F2 Protein-derived Peptide in Lipopolysaccharide-treated Macrophages Iranian Journal of Allergy, Asthma and Immunology Inflammation Influenza A virus Macrophage Polymerase basic–frame-2 |
title | Pro-inflammatory Effects of Influenza Type A Virus PB1-F2 Protein-derived Peptide in Lipopolysaccharide-treated Macrophages |
title_full | Pro-inflammatory Effects of Influenza Type A Virus PB1-F2 Protein-derived Peptide in Lipopolysaccharide-treated Macrophages |
title_fullStr | Pro-inflammatory Effects of Influenza Type A Virus PB1-F2 Protein-derived Peptide in Lipopolysaccharide-treated Macrophages |
title_full_unstemmed | Pro-inflammatory Effects of Influenza Type A Virus PB1-F2 Protein-derived Peptide in Lipopolysaccharide-treated Macrophages |
title_short | Pro-inflammatory Effects of Influenza Type A Virus PB1-F2 Protein-derived Peptide in Lipopolysaccharide-treated Macrophages |
title_sort | pro inflammatory effects of influenza type a virus pb1 f2 protein derived peptide in lipopolysaccharide treated macrophages |
topic | Inflammation Influenza A virus Macrophage Polymerase basic–frame-2 |
url | https://ijaai.tums.ac.ir/index.php/ijaai/article/view/2366 |
work_keys_str_mv | AT kuroshkalantar proinflammatoryeffectsofinfluenzatypeaviruspb1f2proteinderivedpeptideinlipopolysaccharidetreatedmacrophages AT zahrafarzaneh proinflammatoryeffectsofinfluenzatypeaviruspb1f2proteinderivedpeptideinlipopolysaccharidetreatedmacrophages AT nassergholijani proinflammatoryeffectsofinfluenzatypeaviruspb1f2proteinderivedpeptideinlipopolysaccharidetreatedmacrophages AT seyedyouneshosseini proinflammatoryeffectsofinfluenzatypeaviruspb1f2proteinderivedpeptideinlipopolysaccharidetreatedmacrophages AT ebrahimbanihasan proinflammatoryeffectsofinfluenzatypeaviruspb1f2proteinderivedpeptideinlipopolysaccharidetreatedmacrophages |